Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Mar 7;13(3):494.
doi: 10.3390/biom13030494.

Applications of Genomics and Transcriptomics in Precision Medicine for Myopia Control or Prevention

Liqin Jiang  1 , Dong Xuan Goh  2 , James Hao Zhong Koh  1 , Xavier Chan  1 , Noel A Brennan  3 , Veluchamy Amutha Barathi  1   4 , Quan V Hoang  1   4   5
Affiliations
Review

Applications of Genomics and Transcriptomics in Precision Medicine for Myopia Control or Prevention

Liqin Jiang et al. Biomolecules. .

Abstract

Myopia is a globally emerging concern accompanied by multiple medical and socio-economic burdens with no well-established causal treatment to control thus far. The study of the genomics and transcriptomics of myopia treatment is crucial to delineate disease pathways and provide valuable insights for the design of precise and effective therapeutics. A strong understanding of altered biochemical pathways and underlying pathogenesis leading to myopia may facilitate early diagnosis and treatment of myopia, ultimately leading to the development of more effective preventive and therapeutic measures. In this review, we summarize current data about the genomics and transcriptomics of myopia in human and animal models. We also discuss the potential applicability of these findings to precision medicine for myopia treatment.

Keywords: GWAS; Myopia; animal models; genomics; molecular; transcriptomics.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
The general pipeline of precision medicine of a novel myopia therapy from gene discovery to clinical translation.
See this image and copyright information in PMC

References

    1. Holden B.A., Wilson D.A., Jong M., Sankaridurg P., Fricke T.R., Smith E.L., III, Resnikoff S. Myopia: A growing global problem with sight-threatening complications. Community Eye Health. 2015;28:35. - PMC - PubMed
    1. Lin L.L., Shih Y.F., Hsiao C.K., Chen C.J. Prevalence of myopia in Taiwanese schoolchildren: 1983 to 2000. Ann. Acad. Med. Singap. 2004;33:27–33. - PubMed
    1. Williams K.M., Bertelsen G., Cumberland P., Wolfram C., Verhoeven V.J., Anastasopoulos E., Buitendijk G.H., Cougnard-Gregoire A., Creuzot-Garcher C., Erke M.G., et al. Increasing Prevalence of Myopia in Europe and the Impact of Education. Ophthalmology. 2015;122:1489–1497. doi: 10.1016/j.ophtha.2015.03.018. - DOI - PMC - PubMed
    1. Flitcroft D.I., He M., Jonas J.B., Jong M., Naidoo K., Ohno-Matsui K., Rahi J., Resnikoff S., Vitale S., Yannuzzi L. IMI—Defining and Classifying Myopia: A Proposed Set of Standards for Clinical and Epidemiologic Studies. Investig. Ophthalmol. Vis. Sci. 2019;60:M20–M30. doi: 10.1167/iovs.18-25957. - DOI - PMC - PubMed
    1. Leveziel N., Marillet S., Dufour Q., Lichtwitz O., Bentaleb Y., Pelen F., Ingrand P., Bourne R. Prevalence of macular complications related to myopia—Results of a multicenter evaluation of myopic patients in eye clinics in France. Acta. Ophthalmol. 2020;98:e245–e251. doi: 10.1111/aos.14246. - DOI - PMC - PubMed

Publication types

LinkOut - more resources